Dysplasia at the surgical margin is associated with recurrence after resection of non-invasive intraductal papillary mucinous neoplasms

HPB

Volumn 15, Issue 10, 2013, Pages 814-821

  Frankel, Timothy L ^a   Lafemina, Jennifer ^a   Bamboat, Zubin M ^a   D'Angelica, Michael I ^a   Dematteo, Ronald P ^a   Fong, Yuman ^a   Kingham, T Peter ^a   Jarnagin, William R ^a   Allen, Peter J ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER RECURRENCE; DYSPLASIA; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PREDICTIVE VALUE; RECURRENCE RISK; RECURRENT CANCER; SURGICAL ANATOMY;

AGED; CARCINOMA IN SITU; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; PANCREATECTOMY; PANCREATIC NEOPLASMS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84884289373     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12137     Document Type: Article

References (26)

1. D'Angelica M, Brennan MF, Suriawinata AA, Klimstra D, Conlon KC,. (2004) Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome. Ann Surg 239: 400-408.
2. Hara H, Suda K,. (2008) Review of the cytologic features of noninvasive ductal carcinomas of the pancreas: differences from invasive ductal carcinoma. Am J Clin Pathol 129: 115-129.
3. Katabi N, Klimstra DS,. (2008) Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach. J Clin Pathol 61: 1303-1313.
4. Furukawa T, Kloppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, Horii A, et al. (2005) Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 447: 794-799.
5. Zhai J, Sarkar R, Ylagan L,. (2006) Pancreatic mucinous lesions: a retrospective analysis with cytohistological correlation. Diagn Cytopathol 34: 724-730.
6. Tanaka M, Fernandez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. (2012) International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 12: 183-197.
7. Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. (2006) International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 6: 17-32.
8. Hwang HK, Park JS, Kim JK, Park CM, Cho SI, Yoon DS,. (2012) Comparison of efficacy of enucleation and pancreaticoduodenectomy for small (<3 cm) branch duct type intraductal papillary mucinous neoplasm located at the head of pancreas and the uncinate process. Yonsei Med J 53: 106-110.
9. Falconi M, Mantovani W, Crippa S, Mascetta G, Salvia R, Pederzoli P,. (2008) Pancreatic insufficiency after different resections for benign tumours. Br J Surg 95: 85-91.
10. Crippa S, Bassi C, Warshaw AL, Falconi M, Partelli S, Thayer SP, et al. (2007) Middle pancreatectomy: indications, short- and long-term operative outcomes. Ann Surg 246: 69-76.
11. Schnelldorfer T, Sarr MG, Nagorney DM, Zhang L, Smyrk TC, Qin R, et al. (2008) Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg 143: 639-646.
12. Turrini O, Schmidt CM, Pitt HA, Guiramand J, Aguilar-Saavedra JR, Aboudi S, et al. (2011) Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation? HPB 13: 126-131.
13. Okada K, Imaizumi T, Hirabayashi K, Matsuyama M, Yazawa N, Dowaki S, et al. (2010) The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it. J Hepatobiliary Pancreat Sci 17: 516-522.
14. Salvia R, Bassi C, Falconi M, Serini P, Crippa S, Capelli P, et al. (2005) Intraductal papillary mucinous tumors of the pancreas. Surgical treatment: at what point should we stop? JOP 6 (1 Suppl.): 112-117.
15. Fujii T, Kato K, Kodera Y, Kanda M, Nagai S, Yamada S, et al. (2010) Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Surgery 148: 285-290.
16. Leng KM, Wang ZD, Zhao JB, Cui YF, Zhong XY,. (2012) Impact of pancreatic margin status and lymph node metastases on recurrence after resection for invasive and noninvasive intraductal papillary mucinous neoplasms of the pancreas: a meta-analysis. Dig Surg 29: 213-225.
17. White R, D'Angelica M, Katabi N, Tang L, Klimstra D, Fong Y, et al. (2007) Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg 204: 987-993; discussion 93-95.
18. Klibansky DA, Reid-Lombardo KM, Gordon SR, Gardner TB,. (2012) The clinical relevance of the increasing incidence of intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 10: 555-558.
19. Khan S, Sclabas G, Reid-Lombardo KM,. (2010) Population-based epidemiology, risk factors and screening of intraductal papillary mucinous neoplasm patients. World J gastrointest Surg 2: 314-318.
20. Longnecker DS, Adsay NV, Fernandez-del Castillo C, Hruban RH, Kasugai T, Klimstra DS, et al. (2005) Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: interobserver agreement. Pancreas 31: 344-349.
21. Bassi C, Sarr MG, Lillemoe KD, Reber HA,. (2008) Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management. J Gastrointest Surg 12: 645-650.
22. Rivera JA, Fernandez-del Castillo C, Pins M, Compton CC, Lewandrowski KB, Rattner DW, et al. (1997) Pancreatic mucinous ductal ectasia and intraductal papillary neoplasms. A single malignant clinicopathologic entity. Ann Surg 225: 637-644; discussion 44-46.
23. Loftus EV, Jr, Olivares-Pakzad BA, Batts KP, Adkins MC, Stephens DH, Sarr MG, et al. (1996) Intraductal papillary-mucinous tumors of the pancreas: clinicopathologic features, outcome, and nomenclature. Members of the Pancreas Clinic, and Pancreatic Surgeons of Mayo Clinic. Gastroenterology 110: 1909-1918.
24. Raut CP, Cleary KR, Staerkel GA, Abbruzzese JL, Wolff RA, Lee JH, et al. (2006) Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival. Ann Surg Oncol 13: 582-594.
25. Izawa T, Obara T, Tanno S, Mizukami Y, Yanagawa N, Kohgo Y,. (2001) Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer 92: 1807-1817.
26. Lafemina J, Katabi N, Klimstra D, Correa-Gallego C, Gaujoux S, Kingham TP, et al. (2013) Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation. Ann Surg Oncol 20: 440-447.